Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram Biomarkers in Depressed Youth
NCT03547219Completed
- Sponsor
- Seoul National University
- Start
- Aug 2015
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of escitalopram in major depressive disorder (MDD), sponsored by Seoul National University. Primary endpoint: Children's Depression Rating Scale-Revised at 8 weeks. Started Aug 2015; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03547219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03547219.